Remedy Entertainment Oyj Past Earnings Performance
We're still processing the latest earnings report of this company
Past criteria checks 0/6
Remedy Entertainment Oyj's earnings have been declining at an average annual rate of -59.4%, while the Entertainment industry saw earnings growing at 13.2% annually. Revenues have been growing at an average rate of 2.7% per year.
Key information
-59.4%
Earnings growth rate
-59.0%
EPS growth rate
Entertainment Industry Growth | 14.3% |
Revenue growth rate | 2.7% |
Return on equity | -28.4% |
Net Margin | -47.3% |
Next Earnings Update | 12 Feb 2025 |
Recent past performance updates
Recent updates
Investors Interested In Remedy Entertainment Oyj's (HEL:REMEDY) Revenues
Nov 08New Forecasts: Here's What Analysts Think The Future Holds For Remedy Entertainment Oyj (HEL:REMEDY)
Jun 14Analyst Forecasts Just Got A Lot More Bearish On Remedy Entertainment Oyj (HEL:REMEDY)
Feb 20Health Check: How Prudently Does Remedy Entertainment Oyj (HEL:REMEDY) Use Debt?
Oct 27Calculating The Intrinsic Value Of Remedy Entertainment Oyj (HEL:REMEDY)
Sep 15Does Remedy Entertainment Oyj (HEL:REMEDY) Have A Healthy Balance Sheet?
Apr 05Remedy Entertainment Oyj (HEL:REMEDY) Just Reported And Analysts Have Been Cutting Their Estimates
Feb 15The Returns On Capital At Remedy Entertainment Oyj (HEL:REMEDY) Don't Inspire Confidence
Apr 29Remedy Entertainment Oyj (HEL:REMEDY) Has A Pretty Healthy Balance Sheet
Mar 07Remedy Entertainment Oyj (HEL:REMEDY) Shares Could Be 35% Below Their Intrinsic Value Estimate
Feb 16Investors Could Be Concerned With Remedy Entertainment Oyj's (HEL:REMEDY) Returns On Capital
Dec 30Do Remedy Entertainment Oyj's (HEL:REMEDY) Earnings Warrant Your Attention?
May 22Estimating The Intrinsic Value Of Remedy Entertainment Oyj (HEL:REMEDY)
May 04Investors Who Bought Remedy Entertainment Oyj (HEL:REMEDY) Shares Three Years Ago Are Now Up 557%
Mar 07Remedy Entertainment Oyj (HEL:REMEDY) Seems To Use Debt Rather Sparingly
Feb 16Should You Rely On Remedy Entertainment Oyj's (HEL:REMEDY) Earnings Growth?
Feb 04Calculating The Fair Value Of Remedy Entertainment Oyj (HEL:REMEDY)
Jan 19Under The Bonnet, Remedy Entertainment Oyj's (HEL:REMEDY) Returns Look Impressive
Jan 05Is Now The Time To Put Remedy Entertainment Oyj (HEL:REMEDY) On Your Watchlist?
Dec 21Did You Miss Remedy Entertainment Oyj's (HEL:REMEDY) Whopping 388% Share Price Gain?
Dec 06Remedy Entertainment Oyj (HEL:REMEDY) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Nov 20Revenue & Expenses Breakdown
How Remedy Entertainment Oyj makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 39 | -19 | 27 | 0 |
31 Mar 24 | 37 | -21 | 27 | 0 |
31 Dec 23 | 34 | -23 | 27 | 0 |
30 Sep 23 | 36 | -16 | 27 | 0 |
30 Jun 23 | 37 | -9 | 26 | 0 |
31 Mar 23 | 40 | -6 | 25 | 0 |
31 Dec 22 | 44 | -2 | 24 | 0 |
30 Sep 22 | 46 | 3 | 23 | 0 |
30 Jun 22 | 49 | 7 | 23 | 0 |
31 Mar 22 | 47 | 8 | 22 | 0 |
31 Dec 21 | 45 | 9 | 21 | 0 |
30 Sep 21 | 45 | 9 | 21 | 0 |
30 Jun 21 | 45 | 9 | 22 | 0 |
31 Mar 21 | 45 | 10 | 21 | 0 |
31 Dec 20 | 46 | 10 | 21 | 0 |
30 Sep 20 | 42 | 8 | 20 | 0 |
30 Jun 20 | 38 | 7 | 19 | 0 |
31 Mar 20 | 36 | 6 | 18 | 0 |
31 Dec 19 | 33 | 5 | 17 | 0 |
30 Sep 19 | 29 | 4 | 16 | 0 |
30 Jun 19 | 25 | 2 | 14 | 0 |
31 Mar 19 | 23 | 1 | 13 | 0 |
31 Dec 18 | 20 | 1 | 12 | 0 |
30 Jun 18 | 18 | 1 | 11 | 0 |
31 Mar 18 | 18 | 1 | 10 | 0 |
31 Dec 17 | 17 | 1 | 10 | 0 |
31 Dec 16 | 16 | 3 | 8 | 0 |
31 Dec 15 | 14 | 1 | 8 | 0 |
31 Dec 14 | 12 | 2 | 7 | 0 |
Quality Earnings: REMEDY is currently unprofitable.
Growing Profit Margin: REMEDY is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: REMEDY is unprofitable, and losses have increased over the past 5 years at a rate of 59.4% per year.
Accelerating Growth: Unable to compare REMEDY's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: REMEDY is unprofitable, making it difficult to compare its past year earnings growth to the Entertainment industry (5.3%).
Return on Equity
High ROE: REMEDY has a negative Return on Equity (-28.42%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/20 10:40 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Remedy Entertainment Oyj is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Mikael Rautanen | Inderes Oy |
Atte Riikola | Inderes Oy |
Felix Henriksson | Nordea Markets |